Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mayu Onishi"'
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:1240-1250
Autor:
Akari Tanimichi, Jiro Kato, Takeshi Fujii, Arina Uno, Masato Mashimo, Sayaka Yamada, Xiangning Bu, Shigeru Negi, Noriko Sanada, Mana Mori, Joel Moss, Akari Nobeyama, Ryoichi Kizu, Mayu Onishi
Publikováno v:
The Journal of Biological Chemistry
Poly(ADP-ribose) polymerase 1 (PARP1) is a nuclear protein that is activated by binding to DNA lesions and catalyzes poly(ADP-ribosyl)ation of nuclear acceptor proteins, including PARP1 itself, to recruit DNA repair machinery to DNA lesions. When exc
Autor:
Mayu Onishi, Mana Mori, Akari Nobeyama, Takeshi Fujii, Sayaka Yamada, Arina Uno, Akari Tanimichi, Masato Mashimo
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO4-11
Autor:
Masato Mashimo1 mmashimo@dwc.doshisha.ac.jp, Mayu Onishi1, Arina Uno1, Akari Tanimichi1, Akari Nobeyama1, Mana Mori1, Sayaka Yamada1, Shigeru Negi2, Xiangning Bu3, Jiro Kato3, Joel Moss3, Noriko Sanada2, Ryoichi Kizu2, Takeshi Fujii1
Publikováno v:
Journal of Biological Chemistry. Jan-Jun2021, Vol. 296, p1-13. 13p.
Autor:
Toshiya Inaba, Hirotaka Matsui, Mayu Onishi, Shoichi Takahashi, Eiji Iwao, C. Nelson Hayes, Ichimaro Yamada, Tomohiko Kono, Naohiro Kamiya, Akinori Kanai, Kazuaki Chayama, Michio Imamura, Katsutoshi Yoshizato, Hidenori Ochi, Nobuhiko Hiraga, Hiromi Abe, Chise Tateno, Masataka Tsuge, Shinji Tanaka
Publikováno v:
Hepatology. 54:781-788
Telaprevir is a potent inhibitor of hepatitis C virus (HCV) NS3-4A protease. However, the emergence of drug-resistant strains during therapy is a serious problem, and the susceptibility of resistant strains to interferon (IFN), as well as the details
Autor:
Takanori, Kinjo, Yohei, Yamanaka, Kinzo, Katayama, Noriko, Minato, Naoki, Mori, Toshiaki, Yoshioka, Mayu, Onishi, Hiroyuki, Sugahara, Shigeki, Fujita
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 61(7)
Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the prostate is rare. MALT lymphoma with large cell transformation like a diffuse large B-cell lymphoma (DLBCL) of the prostate is extremely rare. To the best of our knowledge, only one cas
Autor:
Takayuki, Ozawa, Satoru, Kosugi, Maiko, Kito, Mayu, Onishi, Toru, Kida, Soichi, Nakata, Hironori, Take, Shuichi, Katagiri
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 55(3)
A 48-year-old woman was hospitalized because of severe thrombocytopenia, leg edema, and fever. Intravenous immunoglobulin therapy was administered, but no efficacy was obtained. Her bone marrow was dry-tap, and fibrosis was found in the biopsy specim
Autor:
Yukiko Uekaji, Keiji Terao, Mayu Onishi, Hidefumi Yoshii, Arja Paananen, Daisuke Nakata, Riitta Partanen
Publikováno v:
Uekaji, Y, Onishi, M, Nakata, D, Terao, K, Paananen, A, Partanen, R & Yoshii, H 2014, ' Micelle Formation of Coenzyme Q 10 with Dipotassium Glycyrrhizate Using Inclusion Complex of Coenzyme Q 10 with γ-Cyclodextrin ', The Journal of Physical Chemistry B, vol. 118, no. 39, pp. 11480-11486 . https://doi.org/10.1021/jp5065165
Micelles can be formed from coenzyme Q10 (CoQ10) and dipotassium glycyrrhizate (GZK2) by using an inclusion complex of CoQ10 with γ-cyclodextrin (γ-CD). The mechanism of micelle formation was kinetically investigated. Adding GZK2 to a supersaturate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04118a9bb1738b1a1b792d483ac6aa10
https://cris.vtt.fi/en/publications/7243a5ca-e668-48a4-acc4-ac34900629cb
https://cris.vtt.fi/en/publications/7243a5ca-e668-48a4-acc4-ac34900629cb
Autor:
Hiromi Abe, C. Nelson Hayes, Ichimaro Yamada, Eiji Iwao, Tomohiko Kono, Naohiro Kamiya, Kazuaki Chayama, Hidenori Ochi, Tomokazu Kawaoka, Masataka Tsuge, Daizaburo Hirata, Nobuhiko Hiraga, Chise Tateno, Shoichi Takahashi, Fukiko Mitsui, Eiji Ohara, Mayu Onishi, Katsutoshi Yoshizato, Shinji Tanaka, Michio Imamura
Publikováno v:
Journal of hepatology. 54(5)
Background & Aims The current treatment regimen for chronic hepatitis C virus (HCV) infection is peg-interferon plus ribavirin combination therapy. The majority of developing therapeutic strategies also contain peg-interferon with or without ribaviri
Autor:
Shinji Tanaka, Kazuaki Chayama, Miwako Tanaka, Kei Shinagawa, Michiyo Kodama, Tomonori Sumida, Wataru Yasui, Yasuhiko Kitadai, Mayu Onishi, Eiji Ohara
Publikováno v:
Cancer Research. 70:1420-1420
Background: Recent studies have revealed that platelet-derived growth factor (PDGF) plays a role in promoting progressive tumor growth in several organs; however, whether PDGF plays a role in gastric cancer is undetermined. We examined whether inhibi